Stock Scorecard
Stock Summary for Health Catalyst Inc (HCAT) - $7.54 as of 11/20/2024 4:09:29 PM EST
Total Score
9 out of 30
Currently on the following lists
None
Tim's Recommendation
Avoid
Growth List Algorithm Criteria for HCAT
| Positive earnings growth | |
| P/E ratio less than Industry P/E Ratio | |
| P/E ratio less than Sector P/E Ratio | |
| P/E ratio that is half the growth rate (or less) | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Positive net income past year and 12 trailing months | |
| Free cash flow ratio greater than 0 and less than 10 |
Small Cap List Algorithm Criteria for HCAT
| Revenue growing by at least 20% average per year over the last 5 years | |
| Market Capitalization under 2 billion | |
| Price to Sales (P/S) ratio 12 trailing months less than Industry P/S ratio twelve trailing months | |
| Price to Sales (P/S) ratio 12 trailing months less than Sector P/S ratio twelve trailing months | |
| Net Income past year > Net Income prior year OR Net Income 12 trailing months > Net Income prior year OR Net Income 12 trailing months > Net Income past year |
Dividend List Algorithm Criteria for HCAT
| Declared an ex-dividend date | |
| Forward annual dividend rate greater than 2 | |
| Positive net cash position the past year and most recent quarter | |
| Equity to debt ratio greater than 0.75 for past year and most recent quarter | |
| Current ratio most recent quarter greater than 2 | |
| Cash Flow per Share greater than Trailing Dividend Rate |
Bonus Criteria for HCAT
| P/E ratio less than five-year Average P/E ratio | |
| Last Price to 52 Week Low Ratio Less Than 1 | |
| Total Cash Per Share > Last Day Price | |
| P/S Ratio < 1 | |
| P/B Ratio < 1 |
Safety Rating Criteria for HCAT (32 out of 90)
| Stock Price Rating (Max of 10) | 4 |
| Historical Stock Price Rating (Max of 10) | 8 |
| Stock Price Trend (Max of 10) | 1 |
| Book Value (Max of 10) | 4 |
| Book Value to Price (Max of 10) | 1 |
| Analyst Buy Ratings (Max of 5) | 5 |
| Analyst Strong Buy Ratings (Max of 5) | 4 |
| Dividend Yield Percentage (Max of 10) | 0 |
| Operating Margin (Max of 10) | 0 |
| Trading Volume (Max of 10) | 5 |
| Price to Earnings (Max of 10) | 0 |
Latest News for for HCAT
Financial Details for HCAT
Company Overview |
|
|---|---|
| Ticker | HCAT |
| Company Name | Health Catalyst Inc |
| Country | USA |
| Description | Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. The company is headquartered in South Jordan, Utah. |
| Sector Name | TECHNOLOGY |
| Industry Name | SERVICES-COMPUTER PROGRAMMING, DATA PROCESSING, ETC. |
| Most Recent Quarter | 9/30/2024 |
| Next Earnings Date | N/A |
Stock Price History |
|
| Last Day Price | 7.54 |
| Price 4 Years Ago | 43.53 |
| Last Day Price Updated | 11/20/2024 4:09:29 PM EST |
| Last Day Volume | 472,361 |
| Average Daily Volume | 502,622 |
| 52-Week High | 11.41 |
| 52-Week Low | 5.42 |
| Last Price to 52 Week Low | 39.11% |
Valuation Measures |
|
| Trailing PE | N/A |
| Industry PE | 103.17 |
| Sector PE | 53.62 |
| 5-Year Average PE | -19.90 |
| Free Cash Flow Ratio | 1.19 |
| Industry Free Cash Flow Ratio | 16.62 |
| Sector Free Cash Flow Ratio | 53.26 |
| Current Ratio Most Recent Quarter | 1.41 |
| Total Cash Per Share | 6.36 |
| Book Value Per Share Most Recent Quarter | 5.83 |
| Price to Book Ratio | 1.29 |
| Industry Price to Book Ratio | 14.96 |
| Sector Price to Book Ratio | 14.91 |
| Price to Sales Ratio Twelve Trailing Months | 1.52 |
| Industry Price to Sales Ratio Twelve Trailing Months | 5.33 |
| Sector Price to Sales Ratio Twelve Trailing Months | 4.97 |
| Analyst Buy Ratings | 7 |
| Analyst Strong Buy Ratings | 3 |
Share Statistics |
|
| Total Shares Outstanding | 60,848,000 |
| Market Capitalization | 458,793,920 |
| Institutional Ownership | N/A |
Dividends |
|
| Ex-Dividend Date | N/A |
| Last Dividend Amount | 0.00 |
| Current Dividend Amount | 0.00 |
| Total Years Dividend Increasing | N/A |
| Trailing Annual Dividend Rate | 0.00 |
| Trailing Annual Dividend Yield | 0.00% |
| Forward Annual Dividend Rate | 0.00 |
| Forward Annual Dividend Yield | 0.00% |
| 5-Year Dividend Payments Count | 0 |
| 3-Year Average Dividend Yield | 0.00% |
| 5-Year Average Dividend Yield | 0.00% |
| 1-Year Dividend Growth Rate Percentage | 0.00% |
| 3-Year Dividend Growth Rate Percentage | 0.00% |
| 5-Year Dividend Growth Rate Percentage | 0.00% |
| All-Time Dividend Growth Rate Percentage | 0.00% |
| Dividend Payout Ratio | N/A |
Income Statement |
|
| Quarterly Earnings Growth YOY | 0.00% |
| Annual Earnings Growth | 14.01% |
| Reported EPS 12 Trailing Months | -1.34 |
| Reported EPS Past Year | 0.24 |
| Reported EPS Prior Year | 0.15 |
| Net Income Twelve Trailing Months | -79,141,000 |
| Net Income Past Year | -118,147,000 |
| Net Income Prior Year | -137,403,000 |
| Quarterly Revenue Growth YOY | 3.50% |
| 5-Year Revenue Growth | 17.69% |
| Operating Margin Twelve Trailing Months | -0.16 |
Balance Sheet |
|
| Total Cash Most Recent Quarter | 387,256,000 |
| Total Cash Past Year | 317,728,000 |
| Total Cash Prior Year | 363,490,000 |
| Net Cash Position Most Recent Quarter | 42,222,000 |
| Net Cash Position Past Year | 89,694,000 |
| Long Term Debt Past Year | 228,034,000 |
| Long Term Debt Prior Year | 226,523,000 |
| Total Debt Most Recent Quarter | 345,034,000 |
| Equity to Debt Ratio Past Year | 0.62 |
| Equity to Debt Ratio Most Recent Quarter | 0.51 |
| Total Stockholder Equity Past Year | 366,919,000 |
| Total Stockholder Equity Prior Year | 425,010,000 |
| Total Stockholder Equity Most Recent Quarter | 355,037,000 |
Free Cash Flow |
|
| Free Cash Flow Twelve Trailing Months | -3,049,000 |
| Free Cash Flow Per Share Twelve Trailing Months | -0.05 |
| Free Cash Flow Past Year | -35,434,000 |
| Free Cash Flow Prior Year | -39,697,000 |
Options |
|
| Put/Call Ratio | 0.00 |
| Has Options | Options Chain |
| Liquidity Rating | |
Technical Analysis |
|
| Yahoo Finance Chart | Yahoo Finance Chart |
| MACD | 0.04 |
| MACD Signal | 0.05 |
| 20-Day Bollinger Lower Band | 6.30 |
| 20-Day Bollinger Middle Band | 7.60 |
| 20-Day Bollinger Upper Band | 8.90 |
| Beta | 1.32 |
| RSI | 43.70 |
| 50-Day SMA | 7.72 |
| 150-Day SMA | 12.00 |
| 200-Day SMA | 21.68 |
System |
|
| Modified | 11/21/2024 2:37:44 AM EST |